Integra LifeSciences Schedules Conference Call for Monday, March 6 to Discuss Fourth Quarter and Full Year 2005 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--Feb. 17, 2006--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM EST on Monday, March 6 to discuss financial results for the fourth quarter and year ended December 31, 2005 and to update forward-looking financial guidance. Financial results for the fourth quarter and full year 2005 will be announced via a news release issued on March 5.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 913-312-1295 or through a webcast via a link provided on Integra's website at http://www.Integra-LS.com. Access to a replay is available through March 20, 2006 by dialing 719-457-0820 (PIN 3248191) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neurosurgery, reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT:
Integra LifeSciences Holdings Corporation
Maria Platsis, 609-936-2333
mplatsis@integra-ls.com
or
David Holtz, 609-936-2334
dholtz@integra-ls.com
SOURCE: Integra LifeSciences Holdings Corporation